Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13D amendment, dated May 22, 2026, relating to the Common Stock, par value $0.001 per share of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
| May 22, 2026 | |||
| (Date) |
|
Casdin Capital, LLC
By: /s/ Eli Casdin | |
| (Signature) | |
| Eli Casdin, Managing Member | |
| (Name/Title) |
|
Casdin Partners Master Fund, L.P.
By: /s/ Eli Casdin | |
| (Signature) | |
| Eli Casdin, Managing Member of its General Partner | |
| (Name/Title) |
|
Casdin Partners GP, LLC
By: /s/ Eli Casdin | |
| (Signature) | |
| Eli Casdin, Managing Member | |
| (Name/Title) | |
| /s/ Eli Casdin | |
| Eli Casdin |